ZEMAIRA Side Effects

6692778-1 | Cataract
on Apr 08, 2010 Female patient from UNITED STATES , weighting 155.0 lb, was diagnosed with alpha-1 anti-trypsin deficiency and was treated with Zemaira (View Usage). Patient experienced the following unwanted or unexpected effects: cataract (What is cataract?). Zemaira dosage: 17 Vials Monthly Intravenous (not Otherwise Specidied). During the same period patient was treated with ACIPHEX (View Aciphex Review and Aciphex Label ), ADVAIR HFA (View Advair Hfa Review and Advair Hfa Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), LUNESTA (View Lunesta Review and Lunesta Label ), COMBIVENT (View Combivent Review and Combivent Label ), CRESTOR (View Crestor Review and Crestor Label ), CELEBREX (View Celebrex Review and Celebrex Label ). Patient was hospitalized and became disabled.

6681971-X | Anaphylactic Reaction
Patient was taking Zemaira (View Usage). Patient had the following side effects: anaphylactic reaction on Mar 31, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 110.0 lb, . Zemaira dosage: (125 Mg, 125 Mg Weekly Intravenous), (60 Mg/kg Intravenous), (intravenous). During the same period patient was treated with ANTIBIOTIC (ANTIBIOTICS) (View Antibiotic (antibiotics) Review and Antibiotic (antibiotics) Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), OSCAL (CALCIUM CARBONATE) (View Oscal (calcium Carbonate) Review and Oscal (calcium Carbonate) Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), FLONASE (View Flonase Review and Flonase Label ). Patient was hospitalized.

6681957-5 |
Adverse event was reported on Mar 30, 2010 by a Female patient taking Zemaira (View Usage) (Dosage: 125 Mg Weekly Intravenous, 60 Mg/kg Intravenous, Intravenous) . Location: UNITED STATES , weighting 110.0 lb, . During the same period patient was treated with PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), OSCAL (CALCIUM CARBONATE) (View Oscal (calcium Carbonate) Review and Oscal (calcium Carbonate) Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), FLONASE (View Flonase Review and Flonase Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ). Patient was hospitalized.

6667351-1 | Hospitalisation
on Mar 11, 2010 Female patient from UNITED STATES , weighting 110.0 lb, was treated with Zemaira (View Usage). Patient experienced the following unwanted or unexpected effects: hospitalisation. Zemaira dosage: 125 Mg, 125 Mg Weekly Intravenous, 60 Mg/kg Intravenous, Intravenous. During the same period patient was treated with PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), OSCAL (CALCIUM CARBONATE) (View Oscal (calcium Carbonate) Review and Oscal (calcium Carbonate) Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), FLONASE (View Flonase Review and Flonase Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ). Patient was hospitalized.


6249234-4 | Abdominal Distension, Abdominal Pain Upper, Blood Pressure Fluctuation, Headache
on Jun 24, 2009 Female patient from UNITED STATES , 64 years of age, weighting 147.0 lb, was treated with Zemaira (View Usage). Patient had the following side effects: abdominal distension, abdominal pain upper, blood pressure fluctuation, headache (What is headache?). Zemaira dosage: 60 Mg/kg 1 Shot Per Week Iv Drip.

5990063-4 | Pneumonia Fungal
Patient was taking Zemaira (View Usage). After Zemaira was administered, patient had the following side effects: pneumonia fungal on Nov 24, 2008 from UNITED STATES Additional patient health information: Female patient , 46 years of age, weighting 230.0 lb, . Zemaira dosage: 5273 Mg Q1w Iv. Patient was hospitalized.

5922574-1 | Pneumonia, Pulmonary Mycosis
Adverse event was reported on Sep 23, 2008 by a Female patient taking Zemaira (View Usage) (Dosage: 6273 Mg Q1w Iv) was diagnosed with alpha-1 anti-trypsin deficiency and. Location: UNITED STATES , 46 years of age, weighting 230.0 lb, Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?), pulmonary mycosis. Patient was hospitalized.

5922419-X | Fungal Infection, Pneumonia
on Oct 06, 2008 Female patient from UNITED STATES , 46 years of age, weighting 230.0 lb, was diagnosed with alpha-1 anti-trypsin deficiency and was treated with Zemaira (View Usage). Patient had the following side effects: fungal infection (What is fungal infection?), pneumonia (What is pneumonia?). Zemaira dosage: 6273 Mg Q1w Iv. Patient was hospitalized.

5922345-6 | Contusion, Dizziness, Infusion Related Reaction, Mental Status Changes, Oropharyngeal Pain, Presyncope, Rash
on Sep 30, 2008 Male patient from UNITED STATES , 41 years of age, was treated with Zemaira (View Usage). After Zemaira was administered, patient had the following side effects: contusion, dizziness (What is dizziness?), infusion related reaction, mental status changes, oropharyngeal pain, presyncope, rash (What is rash?). Zemaira dosage: . Patient was hospitalized.

5877254-8 | Chest Pain, Dyspepsia, Dyspnoea, Fatigue, Feeling Abnormal
Patient was taking Zemaira (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), dyspepsia, dyspnoea, fatigue, feeling abnormal on Aug 21, 2008 from UNITED STATES Additional patient health information: Male patient , 57 years of age, weighting 180.0 lb, was diagnosed with alpha-1 anti-trypsin deficiency and. Zemaira dosage: 60 Mg/kg Daily, Iv. During the same period patient was treated with ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), XOPENEX (View Xopenex Review and Xopenex Label ).

5837789-0 | Bronchitis, Chronic Obstructive Pulmonary Disease, Condition Aggravated, Pneumonia
Adverse event was reported on Jul 24, 2008 by a Male patient taking Zemaira (View Usage) (Dosage: 60 Ug/kg Q1w Iv : 60 Mg/kg Q1w Iv : 60 Mg/kg Q1w Iv) was diagnosed with alpha-1 anti-trypsin decreased and. Location: UNITED STATES , 64 years of age, weighting 180.0 lb, Patient had the following side effects: bronchitis (What is bronchitis?), chronic obstructive pulmonary disease, condition aggravated, pneumonia (What is pneumonia?). During the same period patient was treated with ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ), SINGULAIR (View Singulair Review and Singulair Label ), CELEBREX (View Celebrex Review and Celebrex Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), FLOMAX (View Flomax Review and Flomax Label ), SPIRIVA (View Spiriva Review and Spiriva Label ). Patient was hospitalized.

5781213-3 | Bronchitis, Chronic Obstructive Pulmonary Disease, Condition Aggravated, Dyspnoea, Pneumonia
on May 29, 2008 Male patient from UNITED STATES , 64 years of age, weighting 180.0 lb, was diagnosed with alpha-1 anti-trypsin deficiency and was treated with Zemaira (View Usage). After Zemaira was administered, patient had the following side effects: bronchitis (What is bronchitis?), chronic obstructive pulmonary disease, condition aggravated, dyspnoea, pneumonia (What is pneumonia?). Zemaira dosage: 60 Ug/kg Q1w; Iv,. During the same period patient was treated with ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ), SINGULAIR (View Singulair Review and Singulair Label ), CELEBREX (View Celebrex Review and Celebrex Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), FLOMAX (View Flomax Review and Flomax Label ). Patient was hospitalized.

5773103-7 | Chest Pain, Dyspepsia, Dyspnoea, Fatigue, Muscle Spasms
on May 23, 2008 Male patient from UNITED STATES , 57 years of age, weighting 180.0 lb, was diagnosed with alpha-1 anti-trypsin deficiency and was treated with Zemaira (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), dyspepsia, dyspnoea, fatigue, muscle spasms. Zemaira dosage: 60 Mg/kg Daily Iv; 60 Mg/kg Daily Iv. During the same period patient was treated with ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), KOPENEX (View Kopenex Review and Kopenex Label ).

5751716-6 | Bronchitis, Chronic Obstructive Pulmonary Disease, Condition Aggravated, Pneumonia
Patient was taking Zemaira (View Usage). Patient had the following side effects: bronchitis (What is bronchitis?), chronic obstructive pulmonary disease, condition aggravated, pneumonia (What is pneumonia?) on May 14, 2008 from UNITED STATES Additional patient health information: Male patient , 64 years of age, weighting 180.0 lb, was diagnosed with alpha-1 anti-trypsin deficiency and. Zemaira dosage: 60 Mg/kg Q1w Iv, 60 Mg/kg Q1w Iv. During the same period patient was treated with ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ), SINGULAIR (View Singulair Review and Singulair Label ), CELEBREX (View Celebrex Review and Celebrex Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), FLOMAX (View Flomax Review and Flomax Label ), SPIRIVA (View Spiriva Review and Spiriva Label ). Patient was hospitalized.

5751714-2 | Bronchitis, Chronic Obstructive Pulmonary Disease, Dyspnoea, Pneumonia
Adverse event was reported on May 14, 2008 by a Male patient taking Zemaira (View Usage) (Dosage: 60 Ug/kg Q1w Iv, 60 Mg/kg Q1w Iv, 60 Mg/kg Q1w Iv) was diagnosed with alpha-1 anti-trypsin deficiency and. Location: UNITED STATES , 64 years of age, weighting 180.0 lb, After Zemaira was administered, patient had the following side effects: bronchitis (What is bronchitis?), chronic obstructive pulmonary disease, dyspnoea, pneumonia (What is pneumonia?). During the same period patient was treated with ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ), SINGULAIR (View Singulair Review and Singulair Label ), CELEBREX (View Celebrex Review and Celebrex Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), FLOMAX (View Flomax Review and Flomax Label ). Patient was hospitalized.

5693060-1 | Urticaria
on Apr 02, 2008 Male patient from UNITED STATES , 54 years of age, weighting 180.0 lb, was diagnosed with emphysema and was treated with Zemaira (View Usage). Patient experienced the following unwanted or unexpected effects: urticaria. Zemaira dosage: 60 Mg/kg 85 Kg Weekly Iv.

5649957-1 | Device Occlusion, Empyema, Pleurisy, Pneumonia, Pneumothorax, Prostate Infection, Refusal Of Treatment By Relative, Respiratory Failure, Sepsis
on Feb 06, 2008 Male patient from UNITED STATES , 56 years of age, was diagnosed with alpha-1 anti-trypsin deficiency and was treated with Zemaira (View Usage). Patient had the following side effects: device occlusion, empyema, pleurisy, pneumonia (What is pneumonia?), pneumothorax, prostate infection, refusal of treatment by relative, respiratory failure, sepsis (What is sepsis?). Zemaira dosage: . During the same period patient was treated with SINGULAIR (View Singulair Review and Singulair Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), TRIMETHOPRIM (View Trimethoprim Review and Trimethoprim Label ), NASACORT (View Nasacort Review and Nasacort Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), LEVAQUIN (View Levaquin Review and Levaquin Label ). Patient was hospitalized.

4577277-5 | Cardiac Failure Congestive, Chronic Obstructive Pulmonary Disease, Hangover, Headache, Infusion Related Reaction, Oedema Peripheral, Pitting Oedema
Patient was taking Zemaira (View Usage). After Zemaira was administered, patient had the following side effects: cardiac failure congestive, chronic obstructive pulmonary disease, hangover, headache (What is headache?), infusion related reaction, oedema peripheral, pitting oedema on Jan 20, 2005 from Additional patient health information: Male patient , 43 years of age, was diagnosed with alpha-1 anti-trypsin deficiency and. Zemaira dosage: . Patient was hospitalized.

4564005-2 | Cardiac Failure Congestive, Cardiac Output Decreased, Cardiomegaly, Hangover, Headache, Infusion Related Reaction, Oedema Peripheral, Pitting Oedema
Adverse event was reported on Jan 06, 2005 by a Male patient taking Zemaira (View Usage) (Dosage: ) was diagnosed with alpha-1 anti-trypsin deficiency and. Location: , 43 years of age, Patient experienced the following unwanted or unexpected effects: cardiac failure congestive, cardiac output decreased, cardiomegaly, hangover, headache (What is headache?), infusion related reaction, oedema peripheral, pitting oedema. Patient was hospitalized.

4554468-0 | Cardiac Failure Congestive, Cardiac Output Decreased, Cardiomegaly, Chronic Obstructive Pulmonary Disease, Hangover, Headache, Infusion Related Reaction, Oedema Peripheral, Pitting Oedema
on Dec 30, 2004 Male patient from , 43 years of age, was diagnosed with alpha-1 anti-trypsin deficiency and was treated with Zemaira (View Usage). Patient had the following side effects: cardiac failure congestive, cardiac output decreased, cardiomegaly, chronic obstructive pulmonary disease, hangover, headache (What is headache?), infusion related reaction, oedema peripheral, pitting oedema. Zemaira dosage: . Patient was hospitalized.